CYP2D6 and malaria: This study assessed the safety and efficacy of 0.25 mg/kg single-dose primaquine added to artemether-lumefantrine standard regimen for reducing transmission of P. falciparum gametocytes in patients with uncomplicated malaria based on CYP2D6 alleles common in African Tanzanian.